Home Medtronic Consolidates Core Cardiovascular Businesses to Form New Cardiovascular Surgery Unit

Medtronic Consolidates Core Cardiovascular Businesses to Form New Cardiovascular Surgery Unit

May 07, 2026 09:14 CST Updated 09:14
Medtronic

Medical Device Manufacturer

图片
Instrument Family

Pioneer in Medical Device Media Reports

Share Professional Medical Device Knowledge

Follow

Source:Instrument Family,Reproduction without authorization is prohibited, and reproduction is allowed 24 hours later.

2026Year5Month6DayMedical technology giant Medtronic (NYSE:MDT) Completed significant business architecture adjustments, integrating cardiac surgery with aorticDepartmentMerge to establish the Cardiovascular Surgery Business Unit.This initiative was led by the Senior Vice President of Medtronic and President of the Cardiovascular Surgery division.Karim BandaliThroughLinkedInAnnounce.


Image


According to the disclosure, this merger involves two major core business segments: the original cardiac surgery business, which includes surgical heart valves and extracorporeal membrane oxygenation (ECMO), Left Atrial Appendage (LAA) Occlusion, mitral and tricuspid valve repair, and other technical systems; aortic operations include stent grafts, guidewires, and other interventional treatment products.After the merger, the newly established cardiovascular surgery business will beKarim BandaliUnified leadership to achieve deep integration of R&D, clinical, and market resources.


Image

Karim Bandali


Karim BandaliIndicates:"By integrating our capabilities, we have a powerful opportunity to accelerate innovation, strengthen partnerships with doctors and care teams, and make a greater impact throughout the cardiovascular care continuum." "Our daily focus will be serving more patients tomorrow than today, with a clear emphasis on our Medtronic mission."


Notably, the former head of the aortic businessSimona ZannettiAs of2026Left the job at the beginning of the year, currently serving asArtivionChief Medical Officer and Senior Vice President of Clinical Research. Medtronic stated that this merger aims to accelerate innovation through cross-departmental collaboration, strengthen partnerships with healthcare institutions, and enhance its influence in the full-course management of cardiovascular diseases.


From a strategic perspective, this adjustment continues Medtronic's2020The organizational restructuring launched in the year. At that time, the company underwent strategic reorganization to form20An operating unit, thereafter continuously advancing business integration:2023The year will merge the surgical robot and surgical innovation units into a single surgical business;2024Exited the ventilator market in year, simultaneously integrating patient monitoring and respiratory intervention businesses into Acute Care & Monitoring (ACM) Unit.


Instrument Family believes, MedtronicThis timeThrough continuous optimization of business units, the company is focusing on core tracks to improve operational efficiency. As its traditional advantage sector, the cardiovascular field is expected to further consolidate its leading position in细分 markets such as structural heart disease and aortic diseases through technology synergy and resource integration in this merger.




END
 



Image

BusinessBusiness cooperation email: qxzj@landianyiliao.com